New Diagnostic Tests in Glomerular Disease

CME : 1
Start Date :  Apr 01, 2016End Date :  Apr 01, 2022

Organized by :   Baptist Health South Florida

Specialties :   Nephrology

FeesWebcasts ( Free )

Conference Summary

New Diagnostic Tests in Glomerular Disease is organized by Baptist Health South Florida.

Course opens: 04/01/2016
Course expires: 04/01/2022

Accreditation:
1.00 AMA PRA Category 1 Credit™
1.00 Florida Board of Nursing
1.00 Nurse Practitioners
1.00 General certificate of attendance

Course Description:
Glomerular diseases historically have been challenging disorders to comprehend and treat for patients and physicians alike. Kidney biopsy is the gold standard of diagnosis. Treatment of glomerular disease usually involves therapies that are not specific to disease pathogenesis. Recent progress on the understanding, diagnosis, and treatment of four glomerular diseases: immunoglobulin A nephropathy, focal segmental glomerulosclerosis, the C3 glomerulopathies, and idiopathic membranous nephropathy.

Learning Objectives:
• Identify and understand the mechanisms of  suPAR in focal segmental glomerulosclerosis in chronic kidney disease as well as the potential prognostic role of B7 staining of podocytes.  
• Describe the role of anti PLA2r antibodies in the diagnosis, prognosis and treatment of membranous nephropathy.  
• Summarize the potential role of galactose deficient IgA antibodies and OgG anti-IgA antibodies in the diagnosis and prognosis of IgA Nephropathy. 
• Explain the role of complement and C3 levels in glomerular diseases. 

Additional details will be posted as soon as information is available.

Credit Info

  • CME : 1
Speaker (s)
1 Speaker(s)
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat